MediPharm Labs Corp.
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026
Revenue % change YoY	CA$21.71M N/A	CA$22.11M 1.87%	CA$33.06M 49.48%	Avg: CA$54.93M Low: CA$51.39M High: CA$58.46M avg. 66.16%	Avg: CA$20.21M Low: CA$19.11M High: CA$21.31M avg. -63.20%
Net Income % change YoY	CA$-54.80M N/A	CA$-29.98M 45.28%	CA$-13.08M 56.36%	Avg: CA$-3.45M Low: CA$-3.88M High: CA$-3.37M avg. 73.56%	Avg: CA$135.67M Low: CA$126.06M High: CA$145.24M avg. 4023.42%
EBITDA % change YoY	CA$-37.15M N/A	CA$-25.44M 31.52%	CA$-10.47M 58.81%	Avg: CA$-37.55M Low: CA$-39.96M High: CA$-35.13M avg. -258.37%	Avg: CA$-13.81M Low: CA$-14.56M High: CA$-13.06M avg. 63.20%
EPS % change YoY	-$0.22 N/A	-$0.11 50%	-$0.04 67.27%	Avg: -$0.01 Low: -$0.01 High: -$0.01 avg. 72.22%	Avg: $0.37 Low: $0.35 High: $0.4 avg. 3834.29%
Operating Expenses % change YoY	CA$27.76M N/A	CA$26.87M -3.19%	CA$24.10M -10.30%	Avg: CA$43.29M Low: CA$40.50M High: CA$46.07M avg. 79.60%	Avg: CA$15.93M Low: CA$15.06M High: CA$16.79M avg. -63.20%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 2048.49% in 2025-2026.

We have gathered data from 2 analysts. Their low estimate is -3.88M, average is -3.45M and high is -3.37M.

Wall Street analysts forecast annual average revenue growth of 1.48% in 2025-2026.

We have gathered data from 2 analysts. Their low revenue estimate is CA$51.39M, average is CA$54.93M and high is CA$58.46M.

Wall Street analysts forecast annual average earnings growth of 1953.26% in 2025-2026.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.01, average is -$0.01 and high is CA$-0.00.